Drug Type AAV based gene therapy |
Synonyms BB-HB-331 |
Target |
Action inhibitors |
Mechanism RNAP inhibitors(Bacterial DNA-directed RNA polymerase inhibitors), RNA interference |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatitis B | Preclinical | - | 10 Aug 2022 |